12:00 AM
 | 
Jan 14, 2016
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Leishmania glycosomal phosphoenolpyruvate carboxykinase (PEPCK)

Infectious disease

INDICATION: Leishmaniasis

Mouse and patient sample studies suggest a PEPCK-based vaccine could help treat leishmaniasis. Analysis of parasitic peptides presented by dendritic cells from mice infected with Leishmania major identified a PEPCK peptide, conserved across multiple Leishmania species, that induced...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >